Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.104_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Preliminary Results of a Quality Control Study on Involved Node Radiotherapy in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Treatment of Early Stages Hodgkin Lymphoma During Pregnancy

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2018English

Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Clinico-Biological Characteristics and Treatment Outcomes for Agressive Mantle Cell Lymphoma Patients Included in Clinical Trials. A Lysa Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

PET/CT and Brown Fat in the Evaluation of Treatment Response in Hodgkin Lymphoma

Radiologia Brasileira
Nuclear MedicineRadiologyImaging
2015English

Differences in Outcome of Patients With Syncytial Variant Hodgkin Lymphoma Compared With Typical Nodular Sclerosis Hodgkin Lymphoma

Therapeutic Advances in Hematology
Hematology
2016English

Quantitative Assessment of Interim PET in Hodgkin Lymphoma: An Evaluation of the qPET Method in Adult Patients in the RAPID Trial

PLoS ONE
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy